MeSH Review:
Models, Economic
Whitehouse,
Winblad,
Shostak,
Bhattacharjya,
Brod,
Brodaty,
Dor,
Feldman,
Forette,
Gauthier,
Hay,
Henke,
Hill,
Mastey,
Neumann,
O'Brien,
Pugner,
Sano,
Sawada,
Stone,
Wimo,
Rahme,
Barkun,
Adam,
Bardou,
Annemans,
Warie,
Nechelput,
Peraux,
Rowlett,
Rodefer,
Spealman,
von Scheele,
Peña,
Wong,
Niculescu,
- Cost savings in migraine associated with less chest pain on new triptan therapy. Wang, J.T., Barr, C.E., Torigoe, Y., Wang, E., Rowland, C.R., Goldfarb, S.D. The American journal of managed care. (2002)
- A health economic model to assess the long term effects and cost-effectiveness of PEG IFN alpha-2a in hepatitis C virus infected patients. Annemans, L., Warie, H., Nechelput, M., Peraux, B. Acta Gastroenterol. Belg. (2004)
- A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients. Lamotte, M., Annemans, L., Lefever, A., Nechelput, M., Masure, J. Diabetes Care (2002)
- Is medical treatment for angina the most cost-effective option? Cleland, J.G., Walker, A. Eur. Heart J. (1997)
- Structure and function of the nun gene and the immunity region of the lambdoid phage HK022. Oberto, J., Weisberg, R.A., Gottesman, M.E. J. Mol. Biol. (1989)
- Self-Administration of cocaine-opioid combinations by rhesus monkeys: evaluation of the role of mu receptor efficacy using labor supply analysis. Rowlett, J.K., Rodefer, J.S., Spealman, R.D. J. Pharmacol. Exp. Ther. (2005)
- Treatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDs. Rahme, E., Barkun, A.N., Adam, V., Bardou, M. Drug safety : an international journal of medical toxicology and drug experience. (2004)
- Economic impact of the use of prostaglandin to induce estrus in dairy cows. Fetrow, J., Blanchard, T. J. Am. Vet. Med. Assoc. (1987)
- Economic value of gemcitabine in non-small cell lung cancer. Copley-Merriman, C., Martin, C., Johnson, N., Sacristan, J.A., Drings, P.A., Bosanquet, N. Semin. Oncol. (1996)
- Use of unopposed estrogen in women with uteri: prevalence, clinical implications, and economic consequence. White, V.E., Bennett, L., Raffin, S., Emmett, K., Coleman, M.J. Menopause (New York, N.Y.) (2000)
- The role of single-agent gemcitabine in the treatment of non-small-cell lung cancer. Kelly, K. Ann. Oncol. (1999)
- Economic evaluation of oral valdecoxib versus diclofenac in the treatment of patients with rheumatoid arthritis in a randomized clinical trial. von Scheele, B., Peña, B., Wong, J., Niculescu, L. Rheumatology (Oxford, England) (2003)
- First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary. Whitehouse, P.J., Winblad, B., Shostak, D., Bhattacharjya, A., Brod, M., Brodaty, H., Dor, A., Feldman, H., Forette, F., Gauthier, S., Hay, J., Henke, C., Hill, S., Mastey, V., Neumann, P., O'Brien, B., Pugner, K., Sano, M., Sawada, T., Stone, R., Wimo, A. Alzheimer disease and associated disorders. (1998)
- A cost analysis of bone morphogenetic protein versus autogenous iliac crest bone graft in single-level anterior lumbar fusion. Polly, D.W., Ackerman, S.J., Shaffrey, C.I., Ogilvie, J.W., Wang, J.C., Stralka, S.W., Mafilios, M.S., Heim, S.E., Sandhu, H.S. Orthopedics. (2003)
- An economic model to assess the savings from a clinical application of haematopoietic growth factors. Uyl-de Groot, C.A., Vellenga, E., Rutten, F.F. Eur. J. Cancer (1996)
- Analytic choices in economic models of treatments for rheumatoid arthritis: What makes a difference? Drummond, M.F., Barbieri, M., Wong, J.B. Medical decision making : an international journal of the Society for Medical Decision Making. (2005)
- A literature review of the epidemiology and treatment of acute gout. Kim, K.Y., Ralph Schumacher, H., Hunsche, E., Wertheimer, A.I., Kong, S.X. Clinical therapeutics. (2003)
- An economic model of the market for hospital treatment for non-urgent conditions. Goddard, J.A., Malek, M., Tavakoli, M. Health economics. (1995)